IL6 and pneumonia: Moreover, the study reveals consistent results for crucial biomarkers, such as IL-6 and S100B, exhibiting low variability (I2 < 30%) among the studies, which suggests dependable associations with COVID-19 severity, particularly in pneumonia cases.